跳至主要内容
临床试验/NCT02827071
NCT02827071
终止
不适用

Ocular Imaging Study Using Advanced OCT

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 150 人2016年7月1日

概览

阶段
不适用
干预措施
Retina abnormalities
疾病 / 适应症
Retinal Vascular Disorder
发起方
University of California, Los Angeles
入组人数
150
试验地点
2
主要终点
Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders
状态
终止
最后更新
12天前

概览

简要总结

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

注册库
clinicaltrials.gov
开始日期
2016年7月1日
结束日期
2021年12月9日
最后更新
12天前
研究类型
Observational
性别
All

研究者

责任方
Sponsor
主要研究者

Steven Schwartz

Chief, Retina Division

University of California, Los Angeles

入排标准

入选标准

  • Any patient with abnormal retinal findings as determined by investigators.

排除标准

  • Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
  • Participants who are unable to maintain retinal fixation on a specified target.
  • Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
  • Patients with media opacity which preclude high quality imaging.

研究组 & 干预措施

Retina abnormalities

Subjects with various retina vascular disorders

结局指标

主要结局

Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders

时间窗: 2 years

研究点 (2)

Loading locations...

相似试验